Tratamiento de la hemoglobinuria paroxística nocturna con eculizumab: experiencia en España-Reference-Cited by-同舟云学术

Tratamiento de la hemoglobinuria paroxística nocturna con eculizumab: experiencia en España

Published:2011-06 Issue:1 Volume:137 Page:8-13
ISSN:0025-7753
Container-title:Medicina Clínica
language:es
Short-container-title:Medicina Clínica

Author:

López Rubio Montserrat,Morado Marta,Gaya Ana,Alonso Rosa Dora,Ojeda Emilio,Muñoz Juan Antonio,Pérez de Mendiguren Begoña,Monteagudo María Dolores,Durán José María,Fisac Rosa María,Moreno Damián,Villegas Ana María

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria;Hillmen;N Engl J Med.,2006

2. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria;Brodsky;Blood.,2008

3. Natural history of paroxysmal nocturnal hemoglobinuria;Hillmen;N Engl J Med.,1995

4. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories;De Latour;Blood.,2008

5. Kelly R, Richards S, Arnold L, Valters G, Cullen M, Hill A, et al. A spontaneous reduction of clone size in paroxysmal nocturnal hemoglobinuria patients treated with eculizumab for greater than 12 months. Blood (ASH Annual Meeting Abstracts). 2009. Abstract 1992.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dental infection associated with exuberant gingival necrosis in a patient with paroxysmal nocturnal hemoglobinuria: A case report;Special Care in Dentistry;2020-12-27

2. The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies;Biomedicines;2020-09-16

3. Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications;Cytometry Part B: Clinical Cytometry;2016-10-01

4. Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome;Translational Research;2015-02

5. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria;Cochrane Database of Systematic Reviews;2014-10-30